REGENXBIO (RGNX) CMO Steve Pakola Sells 7,468 Shares

What Happened

• Steve Pakola, Chief Medical Officer of REGENXBIO, had 7,468 shares of company stock withheld/disposed to cover tax withholding on vested restricted stock units. The shares were valued at $9.69 each for a total of $72,365. The transaction is reported as code F (tax withholding) and occurred on 2026-08-01.

Key Details

• Transaction date and price: 2026-08-01 at $9.69 per share.
• Shares disposed/withheld: 7,468 shares; total value ≈ $72,365.
• Transaction type: F = shares withheld to satisfy tax liability upon RSU vesting (not an open-market sale).
• Footnote: These shares were withheld to pay taxes on RSUs originally granted on August 1, 2024; the number withheld was determined using the closing price on August 1, 2026.
• Filing: Form 4 filed 2026-08-04 (filing date shown in the record). The filing itself does not indicate a late filing in the provided data.
• Shares owned after transaction: Not disclosed in the information provided in this summary.

Context

• This was a tax-withholding disposition tied to RSU vesting (a routine administrative transaction), not a discretionary open-market sale. Such withholdings are common and generally reflect tax obligations rather than a signal about the insider’s view of the company. Purchases by insiders are typically more indicative of bullish sentiment than withholding or routine disposals.